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(Xjecdves.We soughtto evaluatethe initialeconomiccost of
primaryangioplastyforacutemyocardialinfarctionundervary-
ing assumptionsaboutwhethera cardiaccatheterization1abora-
tory exists, whetherservices are providedduring night and
weekendhours and howcardiovascularsurgicalbackupis ar-
ranged.
Background,Primaryangioplastyforacutemyocardialinfarc-
tionhas resultedin clinicaloutcomessuperioror equalto those
obtainedwith thrombolysisin recent studies, but its future
implementationdependsgreatlyonits costandcost-effectiveness.
Thereis a gapin knowledgeaboutthetrueeconomiccostsof this
procedure,andunderstandingcostsundera varietyofhypothetic
scenariosis importantin planningwhetherand howthe proce-
dureshouldbe offeredto broadgroupsof patients.
Methods.Ageneralizablespreadsheetmodelwasconstructedto
calculatethecostof primaryangioplastyat a singlehospitalwith
assumptionsbasedon datafroma largenonprofithealthmain-
tenanceorganization(KaiserPermanence),Thefollowingbase-
line assumptionswere made:1) A total of 200 patientswith
myocardialinfarctionpresentedto the hospitaleach year;2)
primaryangioplastywasofferedfor10years;3) thehospitalhad
Duringthe past decade,both intravenousthrombolyiisand
primaryangioplastyhave been found to improveoutcome
among selected patients with acute myocardialinfarction
(l-5). Primaryangioplastymayleadto a betteroutcome,butit




icalcare for heart disease(8,9).
Estimatesof the costof primaryangioplastyundervarying
assumptionsare essentialfor those decidinghow to most
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newexpense,theaveragecostwouldbe 2$3,206.If a newcardiac
catheterizationlaboratoryneededto be built,costswouldrange
from$3,866to $14,339/procedure,dependingon howcardiovas-
cular surgicalbackupwas provided.Resultswere sensitiveto
assumptionsaboutthe annualvolumeof myocardialinfarctions,





policydecisions,a cost-effectivenessmodelis neededthat com-







plastyof $2,500to $3,500,not includingphysicianfees or
hospitalstay (10).However,the fees hospitalschargethird-
party payers often do not represent true economiccosts
becausethe chargesfor mostsemices,especiallyprocedures,
are markedup (11).Physiciansin policymakingpositionsneed
to understandtrue economiccostsbecausehealthcare in the
UnitedStatesis increasinglybeingcoveredunderprospective
paymentsystems.
For primary angioplasty,it is particularlyimportant to
understandpotential costs under a varietyof assumptions
about existingresourcesbecausethe procedurecan onlybe
providedbyhospitalswitha cardiaccatheterizationlaboratory,
and mosthospitalsin the United Statesdo not havesuch a
facility(12,13).Physiciansandhospitalswithsucha laboratory
need to determinethe hourstheywillprovideprimaryangio-
plastyservices;thosewithoutlaboratoriesmustdecidewhether
tobuildfacilities,triagepatientselsewhereordenypatientsthe
procedure.To determinewhen primaryangioplastyis cost-









Table1. Costs of Primary AngioplastyUnder VaryingAssumptionsAbout Resources*
Present Projected
Elective Vafueof Annunl ProjectedCost






forTechnical Cardiovascular (angioplasty/ Primary Angioplasty~ Angioplasty Procedure
Scenario Laboratory Staff SurgicalBackup angiography) Angioplasty (Us. $) Procedures (Us. $)
A Exists Exists Exists NA All 1,347,000 84 1,597
B Exists NA Exits NA Weekdays 616,000 39 1,597
c Exists Newexpense Exists NA Nightsand 2,088,000 45 4,564
weekends (incremental
Cost*)
D Exists Newexpense Transport$ NA Afl 2,704,000 84 3,206
E Existsll Newexpense Exists NA All 2,230,000 84 2,644
F Newexpense Newexpense Transports 0/0 AfI 6,230,000 84 7,387
G Newexpense Newexpense Transport$ 100/700 All 3,261,000 84 3,866
H Newexpense Newexpense Startnewprogram 0/0 Afl 8,184,000 84 9,704
withtwoother
hospitals
I Newexpense Newexpense Startnewprogrmn 0/0 M 12,093,000 84 14,339
*Intheseestimates,the numberofpatientspresentingto thehospitalwithmyocardialinfarctionannualfyis heldconstantat 200,andthe numberofyearsthat








plastyto patientswith myocardialinfarctionpresentingto a
singlehospital.Themodelallowedvaryingassumptionsabout
1) whether a cardiaccatheterizationlaboratoryexisted,2)
whether serviceswere providedduringnight and weekend
hours, and 3) how cardiovascularsurgicalbackupwas ar-
ranged.Furthermore,we examinedvariationsin the cost of
primaryangioplastyas we alteredoverplausiblerangesboth
thenumberofacutemyocardialinfarctionstreatedannuallyat
the hospitaland the numberof yearsthe procedurewasthe
preferredmodeof therapy.
Methods
Model setting. A generalizablespreadsheetmodel was
constructedto calculatethe costsof offeringprima~ angio-
plastyfor acutemyocardialinfarction.Probabilitiesof health
outcomeswerederivedfrompublishedsources,andcostswere
basedon estimatesprovidedby administratorsin the Kaiser
PermanenceMedicalCare Programof NorthernCalifornia;
theseinputsare discussedin detaillater.KaiserPermanenceis
a nonprofit,group model health maintenanceorganization
whosephysiciansreceivesalariesbasedon timeworked.The
healthmaintenanceorganizationprovidesthe fullspectrumof
services,from preventiveto tertiaq care, to -2.4 million
patientsovera regionthat includes17hospitalsin the greater
San FranciscoBay and Sacramentoareas. Patientsneeding
electivecardiacproceduresare treatedat oneoftheprogram’s
three cardiaccatheterizationlaboratoriesor are referred to
communityhospitalsoutsidethe program.




modeledon data from Kaiser Permaqente’sSan Francisco
hospital,whosecardiaccatheterizationlaboratoryoperated
weekdaysbetween8 AMand 5 PM. Cardiovascularsurgical
backup was already available.The cardiac catheterization






alone were already providedfor 6,760 h annually,which
includednights,weekendsand holidays(8,760h in a year
minus2,000h duringthe 250weekdays).If calledin to work,
technicalstaffreceiveda higherrate of pay for thosehours
actuallyworked.Cardiologistsand cardiovascularsurgeons
alreadyare oncall,andno extrafeesfor theiravailabilitywere
assumed.
Regionaland local administrationwere calculatedas a
percentoflaborcosts.In thebaselinescenario,itwasassumed
that the costsof maintenanceof the buildingand equipment
for the cardiovascularcatheterizationlaboratoryand,cardio-
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tories,the availabilityof on-calltechnicalpersonneland car-
diovascularsurgicalbackupvaries.Thus,we modeledseveral
alternativescenariosin whichthe hoursof offeringprimary





and cannot be treated with thrombolysis(14,15).In the
scenarioin whichprimaryangioplastywas routinelyoffered
onlyduringweekdays(B),it wasassumedthat the procedure
wouldbeprovidedduringnightsorweekendsto thosepatients
withhighriskcharacteristics.Althoughthesepatientscomprise
only990 of all patientswithmyocardialinfarction,theyhave
>25% of the 35%of myocardialinfarctionsthat are eligible




In somehospitals,technicalstafflabormaybea tied rather
than a variablecost.ScenarioE assumedthat technicalstaff
costswere tixedand that the laboratorywasnot operatingat
fullcapacityfor electiveprocedures.In thiscircumstance,the
costof technicalstafflaborforprimaryangioplastyprocedures
would,in effect,be zeroasthe technicalstaffwouldhaveextra
timeavailable.
From a regionalor nationalpolicymaker’standpoint,a
crucialfactorin decisionsaboutprimaryangioplastyis the fact
that equippinga hospitalwitha cardiaccatheterizationlabo-
ratoryrequiresa large initialinvestment.Thus,we modeled
severalalternativescenariosin whichit wasassumedthat no
cardiac catheterizationlaboratorycurrentlyexisted at the
hospitaland onewouldbe builtexpresslyto provideprimary
angioplasty.The costsof buildingand equippingthe cardiac
catheterizationlaborato~ and maintainingthe equipment
wereaddedto the othercostsof providingthe service.
In northernCaliforniaand manyotherurbanareas,excess
capacityfor elective angioplastyand angiographyalready
exists.A newcardiovascularcatheterizationlaboratorywould
merelybe takingproceduresawayfrom previouslyexisting
laboratoriesin the geographicarea. In such situations,the
economiccost of buildingand equippinga new laboratory
shouldbe attributedentirelyto primaryangioplasty.There-
fore, in our scenariosthe number of electiveprocedures
performedat the newfacilitywas initiallyset at O—implying
that no costof the laboratorywasallocatedto theseelective
procedures.
In contrast,scenarioG describedan area where elective
procedureshadbeengoingunperformedforwantof a cardiac
catheterizationlaboratory.In this scenario,it wasrealisticto
apportion a part of the laboratorycost to these elective
















































*Assumptionsare from KaiserPermanenceMedicalCare Programof
NorthernCaliforniaexceptasotherwisenoted.tEstimateisbasedonpublished
studies(15,16).$EstimateisfromtheChestPainStudy(19).$Estimateisfrom






provideon-sitebackupand that its costswouldbe chargedin
fullagainstthe primaryangioplastyprogram.
Probabilitiesand costs. Table 2 showsthe probabilities
and costsused in the model.The proportionof myocardial
infarctionseligiblefor primaryangioplastyand of myocardial
infarctionsoccurringduringweekdayhourswasestimatedon
the basisof publishedsourcesand analysisof KaiserPerrna-
nente data (14-18).Patientswere definedas eligibleif they
presentedwithin6h oftheonsetofsymptomsandhad zl-mm




seeminglyeligiblepatientswith chest pain and ST segment
elevationdo not trulyhavemyocardialinfarction(19);how-
ever, it was assumedthat primaryangioplastywouldbe at-
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devote 4 h, includingtime for preoperativeand follow-up
examinationsandpaperwork;a registerednurseanda cardiac
catheterizationlaboratorytechnicianwouldeachdevote2 h; a
supervisingnursewouldspend0.6h and a medicalsecretag
and clericalperson would each spend 1 h. Supplycosts









last 10 years and to have no resalevalueat any time after
purchase.For cardiovascularsurgicalbackup,4% of patients
receivingprimaryangioplastywere assumedto need emer-
gencyCABG.Transportto a neighboringhospitalfor this
operation was assumedto cost $500,but the cost of the
emergencyCABGitselfwas not added to the total cost of
primaryangioplasty.To start a new cardiovascularsurgical
program,twocardiovascularsurgeonsand an anesthesiologist





tion that primaryangioplastywouldbe providedfor 10years.
Future costswere discountedat a rate of 5%/year.Results
were expressedas the averagecostper primaryangioplasty.
Future prima~ angioplastyprocedureswere not discounted;
furtheranalysesthat translateprimaryangioplastyprocedures
into health benefitssuch as life-yearssavedwouldneed to
discountfuturehealthbenefits(20).
Sensitivity analyses. Uncertaintysurroundsthe assump-





the discountrate. Becausethe future is uncertainand new
thrombolyticagentsor other noninvasiveinterventionscould




The estimatedtotal cost and costper primaryangioplasty
procedurefor each scenarioare shownin Table 1. In the
baseline scenario (A), assumingthe hospital treated 200
myocardialinfarctions/year,providingprimary angioplasty
duringallhourswasestimatedto resultin 84proceduresat a
costof $1,597/procedure.If the hospitalhad a lalmrato~ but
technicalpersonnelwere not on call at night,providingpri-
mary angioplastyonly duringweekdays(scenarioB) would
resultin39proceduresat a costof$1,597/procedure.Providing
fullserviceon nightsandweekends(scenarioC) wouldresult
in 45 additionalprocedureson nightsand weekendsat an
incrementalcostof $4,564/procedure.
In scenarioswithout an existingcardiac catheterization
laboratory,theprojectedcostofprimaryangioplastywasmuch
higher. If a. new laboratorywere built and cardiovascular
surgicalbackupwere arrangedthroughtransportto a neigh-
boringhospital(scenarioF), the costper primaryangioplasty
wouldbe $7,387.If the newcardiaccatheterizationlaboratory
were assumedto also provide electiveproceduresover a
10-yearlifespan(scenarioG), thecostperprimaryangioplasty
wouldbe reducedto $3,866.If a newcardiovascularsurgical













weekdayprocedures.In the worst-casescenario,if primary
angioplastywere offered by a hospital that had only 50
myocardialinfarctionsannuallyandthatneededto constructa
cardiaccatheterizationlaboratoryand start a newcardiovas-




currentlyexist,the costof prima~ angioplastywasdependent
on thenumberofyearsthe servicewouldbe provided(Fig.2).
Doublingthe time frame to 20 years had little effect,but
shorteningit to <8 years markedlyincreasedthe cost of
offeringthe procedure.In the worst-casescenario-if a labo-
ratory were built, a new cardiovascularsurgicalprogram






dial infarctionsthat wouldbe eligiblefor the procedure.The
effectsof varyingthe proportionof myocardialinfarctions
eligiblefromOto 7070and of varyingthe annualnumberof
myocardialinfarctionsfrom Oto 400were identicalbecause
bothvariablesdirectlyaffectedthe numberof primaryangio-
plastyprocedures(Fig.1).
Electiveprocedures.In the scenario(G) in whicha new
cardiaccatheterizationlaboratorywasbeingbuiltand elective
angioplastyandangiographywereassumedto be chargedwith
part of these costs, the cost of primary angioplastywas
886 LIEU ET AL.
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o 50 100 160 200 250 300 350 400I Number of myocardial infarotiona per year(holding% eligibleconstantat 35%)I
10 9’% 18”A 26% 35% 44Y0 52% 62% 70%
Proportion of myocardial Infarctions eligible for primsiy angioplasty
(holdingnumber of myocerdialinfarctionsper year constantat 200)
relativelyinsensitiveto increasingthe numbersof elective
proceduresbeyond100electiveangioplastyproceduresand
700 angiographicstudies.For example,the cost of primary
angioplastydecreasedonlyto $3,356(fromthe baselineesti-
mate of $3,866)as the numbersof electiveangioplastyand
angiographicprocedureswere increasedto 550 and 3,450,
respectively.The costof primaryangioplastywasmoresensi-
tiveto decreasingthe numbersof electiveproceduresbelow
baselineestimates.If the laboratoryperformedonly50elective
angioplastyand 350 angiographicprocedures,the cost per
primaryangioplastywas$4,346.
























cal staffwasnot a newexpense,were minimallysensitiveto
varyinglaborcostsbetween5070and 150~0of baselineesti-




I) in whicha cardiaccatheterizationlaborato~ neededto be
built,the costof primaryangioplastywassensitiveto the cost
ofconstructionandequipment(Table3).However,thecostof
primaryangioplastywas minimallysensitiveto the cost of
buildingand equippingthe laboratoryin scenarioG, in which
the costof the laboratorywascountedagainstelectiveproce-
duresaswellas primaryangioplasty.
Figure2. Sensitivityanalysisshowingthe cost per primary
angioplasty procedure as the number of years that the
service is provided is varied. All scenarios in this figure
assume that a new cardiac catheterization laboratory is
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Table3. Cost ofPrimaryAngioplastyUnderVaryingAssumptionsAboutLabor,Constructiona d
EquipmentCosts
Cost/PrimaryAngioplasty(U.S.$)
50%of 80%of 120%of 150%of
Baseline Baseline Baseline Baseline Baseline
Sensitivityto laborcosts
ScenarioD 3,206 1,805 2,549 3,992 5,412
ScenarioE 2,644 1,437 2,065 3,352 4,655
ScenarioF 7,387 5,986 6,730 8,173 9,593
ScenarioG 3,866 2,465 3,209 4,652 6,072
ScenarioH 9,704 7,270 8,634 10,903 12,943
ScenarioI 14,339 9,838 12,442 16,364 19,644
Sensitivityto construction
andequipmentcosts
ScenarioF 7,387 5,297 6,551 8,223 9,478
ScenarioG 3,866 3,536 3,734 3,998 4,196
ScenarioH 9,704 7,488 8,818 10,591 11,920





systems.In this context, it is crucial for cardiologiststo
understandthe actualcostsof clinicalservicesundervarious
managementscenarios(11).In manycountries,the futureof
primaryangioplastyas an interventionfor acute myocardial
infarctiondependsnot onlyon clinicaldata but alsoon cost
data (6,21,22).The currentstudyquestionsthe conventional
wisdomthat the initialcostof a primaryangioplastyprocedure
is higherthan that of a dose of a thrombolyticagent.In a
nonprofit,high-volumesettingwithan existingcardiaccathe-
terization laboratory,the $1,597initial cost of a primary
angioplastyprocedureis lowerthan that of a dose of tissue
plasminogenactivator.
Theseresultsshowthat the costof offeringprimaryangio-
plastywillvarywidelydependingon thevolumeofprocedures,
existingresourcesat a given hospitaland the method of
providingcardiovascularsurgicalbackup.Thecostperprimary
angioplastyincreasesexponentiallyas the numberof myocar-
dial infarctionstreated at the hospitaldecreasesto <100
annually,or the number of years the procedure is used
decreasesto <6. In addition,ifnightcallfor technicalperson-
nel is a new expenseor a cardiaccatheterizationlaboratory
needsto bebuilt,thecostperprimaryangioplastyisdoublethe
mostoptimisticestimate,at 2$3,206/procedure.
Policy implications. Decisionsaboutwhetherto offerpri-
maryangioplastyshouldbeginwiththe evidenceon itsclinical
effectiveness.If recent findings(3-5,23)that the resultsof
primaryangioplastyare superioror equalto thoseof throm-
bolysiscan be generalized,then the procedure’scost and




showwhetherprimaryangioplastywillbe cost-effectiveif it is
offeredunder conditionsthat differfrom those in empiric
studies.The currentmodelprovidesa foundationfor further
studyoftheprojectedcost-effectivenessofprimaryangioplasty
undervariouspopulation-basedstrategiesfor offeringit.
The resultsof this study do not providecompletedata
becausetheyfocusonlyon the initialcostof primaryangio-
plasty,whichmaybeoffsetbya shorterhospitalstayandlower
rates of future angioplastyand CABGthan thoseassociated
with thrombolysis(3,27,28).To better informclinicalpolicy
decisions,a cost-effectivenessmodelthatcombinestheseinitial




amongsumivors;lengthof hospitalstay;rate of subsequent








out a cardiaccatheterizationlaboratory.However,it hasbeen
suggested(29–31)that angioplastyservicesshouldbe region-
alizedbecauseclinicaloutcomestend to be better at higher
volumehospitals(29-31).This study’sresultsadd economic
weightto this argument.The current findingsconfirmthe
belief(24)that buildingnewlaboratoriesto provideprimary
angioplastyat lowvolumehospitalswouldhaveextremelyhigh
economiccosts,particularlyin urban areas that alreadyhave
excessexistingcapacityfor electiveprocedures.
It hasbeen suggestedthat performingangioplastywithout
on-site cardiovascularsurgicalbackup may sometimesbe
888 LIEU ET AL.
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acceptable, although this practice remains controversial
(32s3). These resultsshowthat startingnew cardiovascular
surgicalprogramsmainlytobackupprimaryangioplastywould
morethan doublethe costof offeringprimaryangioplasty.In





Comparisonsand study limitations. The $1,597cost of
primaryangioplastyin thisstudy’smostoptimisticscenariois
far lowerthan the $7,556foundby usinga university-based
hospital’saccountingsystemor the $6,635Medicarediagnosis-
related-groupreimbursementrate for North Carolina(34).
One reasonis that the currentstudy’sbaselinecost assump-
tions focuson the cost of addingprimaryangioplastyto an
alreadyoperatinglaboratory.Thus,unlikethe assessmentof a
typicalhospitalaccountingsystem,our most optimisticsce-





Thissettingwaschosenas the sourceof baselineassumptions
becausecostsin a largenonprofitgrouppracticeare lesslikely
to be distortedby costshiftingor contractingdiscountsthan
are indemnity-basedchargesto third-partypayersor price-
based costs from stand-alonehospitals.Thus, the costs re-
ported here should be closer to the true economiccosts
experiencedby large groupsof providersand patients. In
sensitivityanalyses,costinputsto thismodelwerevariedover
wideranges;thesevariationsresultedin changesin the abso-
lutecostofprimaryangioplastybutnot in the model’sgeneral
findings.
Our baselinescenariowithan existingcardiaccatheteriza-
tion laboratoryassumedthat it operatedat full capacityfor
electiveproceduresand,thus,laborcostswerevariable.How-
ever, manyU.S. cardiaccatheterizationlaboratoriesdo not
operate at peak volume(29,30).A cardiaccatheterization
laboratorythat was underutilizedmight treat the cost of
cardiologistandtechnicalpersonnelsalariesasfixed.Although
its accountingsystemwouldprobablyreporthighercoststhan
thosein this study,scenarioE in this analysisshowsthat the
true costof addingprimaryangioplastyservicesin this situa-
tionwouldactuallybe lowerthan if laborcostswerevariable.
Finally,becausethe costs in this model are discountedin
futureyearsand averagedovera periodofyears,the average
costs expressedare less than the nominalexpenditureson
primaryangioplastyin anygivenyear.
Conclusions.Weconcludethat the initialcostofa primary
angioplastyprocedureunderidealcircumstancesisreasonable
comparedwiththat of the moreexpensivethrombolyticagent
inwidespreaduse.However,prima~ angioplastywouldcost3
to 10timesasmuchat hospitalswithoutfullexistingresources,
and would cost even more at hospitalsthat treated <200
patientswithmyocardialinfarctionannually.Policydecisions
on primaryangioplastywillneed to weighnot onlythe initial
costspresentedhere,but alsothe relativehealthbenefitsand
long-termcostsof thrombolysisand primaryangioplasty.Fur-
ther studiesthat compare the long-termeffectivenessand
cost-effectivenessof these interventionsfrom a population-
basedperspectiveare needed.
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